Yixue xinzhi zazhi (Jun 2020)
Evidence-based Chinese expert recommendations on drug prevention,diagnosis, treatment, and discharge management of covid-19 a protocol
- Ying-Hui JIN,
- Hong-Jun LI,
- Qing-Yuan ZHAN,
- Zhi-Yong PENG,
- Yu-Feng YUAN,
- Lin CAI,
- Xun-Tao YIN,
- Ji-Rong YUE,
- Qi-Wen YANG,
- Jian-guang JI,
- Jian XIA,
- Yi-Rong LI,
- Fu-Xiang ZHOU,
- Ya-Dong GAO,
- Zhui YU,
- Feng XU,
- Xiao-Chun ZHANG,
- Ming-Li TU,
- Li-Ming TAN,
- Xue-Qun REN,
- Min YANG,
- Fang CHEN,
- Xiao-Ju ZHANG,
- Mei ZENG,
- Yu ZHU,
- Xin-Can LIU,
- Jian YANG,
- Dong-Chi ZHAO,
- Yu-Feng DING,
- Ning HOU,
- Fu-Bing WANG,
- Hao CHEN,
- Yong-Gang ZHANG,
- Wei LI,
- Wen CHEN,
- Yue-Xian SHI,
- Xiu-Zhi YANG,
- Xue-Jun WANG,
- Yan-Jun ZHONG,
- Tong DENG,
- Jin-Ping GAO,
- Shao-Fu YU,
- Man-Ru FAN,
- Hong-Yang XUE,
- Lin-Xin YU,
- Bing-Hui LI,
- Lu-Yao LI,
- Lin-Lu MA,
- Xiang-Ying REN,
- Na WANG,
- Hong WENG,
- Ming-Juan ZHAO,
- Hao ZI,
- Di HUANG,
- Li-Sha LUO,
- Qiao HUANG,
- Yun-Yun WANG,
- Xian-Tao ZENG,
- Zhen-Shun CHENG,
- Xiao-Mei YAO,
- Xing-Huan WANG
Affiliations
- Ying-Hui JIN
- Hong-Jun LI
- Qing-Yuan ZHAN
- Zhi-Yong PENG
- Yu-Feng YUAN
- Lin CAI
- Xun-Tao YIN
- Ji-Rong YUE
- Qi-Wen YANG
- Jian-guang JI
- Jian XIA
- Yi-Rong LI
- Fu-Xiang ZHOU
- Ya-Dong GAO
- Zhui YU
- Feng XU
- Xiao-Chun ZHANG
- Ming-Li TU
- Li-Ming TAN
- Xue-Qun REN
- Min YANG
- Fang CHEN
- Xiao-Ju ZHANG
- Mei ZENG
- Yu ZHU
- Xin-Can LIU
- Jian YANG
- Dong-Chi ZHAO
- Yu-Feng DING
- Ning HOU
- Fu-Bing WANG
- Hao CHEN
- Yong-Gang ZHANG
- Wei LI
- Wen CHEN
- Yue-Xian SHI
- Xiu-Zhi YANG
- Xue-Jun WANG
- Yan-Jun ZHONG
- Tong DENG
- Jin-Ping GAO
- Shao-Fu YU
- Man-Ru FAN
- Hong-Yang XUE
- Lin-Xin YU
- Bing-Hui LI
- Lu-Yao LI
- Lin-Lu MA
- Xiang-Ying REN
- Na WANG
- Hong WENG
- Ming-Juan ZHAO
- Hao ZI
- Di HUANG
- Li-Sha LUO
- Qiao HUANG
- Yun-Yun WANG
- Xian-Tao ZENG
- Zhen-Shun CHENG
- Xiao-Mei YAO
- Xing-Huan WANG
- DOI
- https://doi.org/10.12173/j.issn.1004-5511.2020.03.07
- Journal volume & issue
-
Vol. 30,
no. 3
pp. 209 – 226
Abstract
This is the protocol of updated our previously guideline named “A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)”. This protocol included guideline methodology, target users, target population, conflict of interest policy, evidence searching, review and assessment, grading of evidence and recommendations development of recommendations, and updating plan. We also attached three appendices for readers: list of clinical questions, searching strategies, survey questionnaire of conflict of interest.
Keywords
- 2019-ncov
- covid-19
- drug prevention
- diagnosis
- treatment
- discharge management
- clinical practice guideline